Decreased rates of advanced breast cancer due to mammography screening in The Netherlands
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6602075.pdf
Reference28 articles.
1. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419–427
2. Boer R, Warmerdam P, de Koning H, van Oortmarssen G (1994) Extra incidence caused by mammographic screening (letter). Lancet 343: 979
3. Botha JL, Bray F, Sankila R, Parkin DM (2003) Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39: 1718–1729
4. Buiatti E, Barchielli A, Bartolacci S, Federico M, De Lisi V, Bucchi L, Ferretti S, Paci E, Segnan N, Tumino R (2003) The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas. Eur J Cancer 39: 1776–1782
5. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK (1996) Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88: 1571–1579
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stage I Breast Cancer in the Modern Era: A Retrospective Cohort Study of 328 Patients Diagnosed from 2002 to 2006 with a 14-Year Median Follow-Up;Oncology;2024
2. The Effect of Intraoperative Margin Assessment During Breast Conserving Surgery for Breast Cancer in a Dutch Cohort;Clinical Breast Cancer;2024-01
3. Stage I (T1N0M0) breast cancer with a median follow-up of 14 years: A retrospective cohort study of 328 consecutive patients and the prognostic value of tumor size, grade, and subtype;2023-10-06
4. Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach;Scientific Reports;2023-08-22
5. Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database;Gland Surgery;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3